Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sana Biotechnology (SANA)
NASDAQ:SANA
Sana Biotechnology (SANA) Ownership - Who Owns Sana Biotechnology?
225 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 11, 2024 | Patrick Yang Director | Sold | $236250 |
| Feb 12, 2024 | Robert Nelsen Director, >10% Owner | Bought | $9999996 |
| Feb 12, 2024 | Keith Crandell >10% Owner | Bought | $9999996 |
| Feb 12, 2024 | Arch Venture Fund X, L.p. >10% Owner | Bought | $9999996 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $17570 | |
| Mar 31, 2024 | Bought | $842590 | |
| Mar 31, 2024 | Bought | $8990500 | |
| Mar 31, 2024 | Bought | $9840000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,001,856 | Institution | 11.29% | 130,509,688 | |
| 12,099,576 | Institution | 5.46% | 63,159,787 | |
| 10,916,078 | Institution | 4.93% | 56,981,927 | |
| 7,239,591 | Institution | 3.27% | 37,790,665 | |
| 6,066,500 | Institution | 2.74% | 31,667,130 | |
| 5,881,106 | Institution | 2.66% | 30,699,373 | |
| 3,626,465 | Institution | 1.64% | 18,930,147 | |
| 2,662,106 | Institution | 1.20% | 13,896,193 | |
| 2,489,607 | Institution | 1.12% | 12,995,749 | |
| 2,380,949 | Institution | 1.07% | 12,428,554 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,916,078 | Institution | 4.93% | 56,981,927 | |
| 7,239,591 | Institution | 3.27% | 37,790,665 | |
| 5,881,106 | Institution | 2.66% | 30,699,373 | |
| 2,662,106 | Institution | 1.20% | 13,896,193 | |
| 2,489,607 | Institution | 1.12% | 12,995,749 | |
| 2,059,966 | Institution | 0.93% | 10,753,023 | |
| 1,592,844 | Institution | 0.72% | 8,314,646 | |
| 1,331,094 | Institution | 0.60% | 6,948,311 | |
| 1,091,497 | Institution | 0.49% | 5,697,614 | |
| 1,051,316 | Institution | 0.47% | 5,487,870 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,183,187 | Institution | 1.89% | 31,373,903 | |
| 3,349,126 | Institution | 1.51% | 25,118,445 | |
| 3,453,689 | Institution | 1.56% | 18,477,236 | |
| 3,194,690 | Institution | 1.44% | 16,676,282 | |
| 1,906,405 | Institution | 0.86% | 14,298,038 | |
| 1,628,948 | Institution | 0.74% | 12,217,110 | |
| 1,168,831 | Institution | 0.53% | 6,101,298 | |
| 887,063 | Institution | 0.40% | 4,630,469 | |
| 445,754 | Institution | 0.20% | 3,343,155 | |
| 511,610 | Institution | 0.23% | 2,737,114 |
FAQ
Who Owns Sana Biotechnology (SANA)?
Currently, no data Available
What percentage of Sana Biotechnology (SANA) stock is held by institutional investors?
Currently, no data Available
What percentage of Sana Biotechnology (SANA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Sana Biotechnology (SANA)?
Noubar Afeyan owns the most shares of Sana Biotechnology (SANA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.